Jeffrey Yu Buys Shares of OneMedNet Corporation
OneMedNet's Chief Medical Officer, Jeffrey Yu, purchased 158,730 shares at $0.63 each.
Key Points
- Jeffrey Yu, Chief Medical Officer of OneMedNet Corporation, bought 158,730 shares on June 23, 2026, at $0.63 per share, totaling nearly $100,000.
- Shares of ONMD traded at $0.64 on Wednesday, with a market cap of approximately $30.4 million and a 52-week range of $0.34 to $4.22.
- Other institutions like Exencial Wealth Advisors and Vanguard Capital Management also adjusted their positions in OneMedNet.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 23, 2026, Jeffrey Yu, the Chief Medical Officer of OneMedNet Corporation, made a notable purchase of 158,730 shares at a price of $0.63 each. This transaction was not part of a pre-arranged trading plan and was valued at nearly $100,000.
Insider Buying and Selling at OneMedNet Corporation
Jeffrey Yu wasn't the only insider active in June. On the same day he made his purchase, Aaron Green, the CEO, also acquired 36,650 shares at $0.57 each. Earlier that month, Yu added another 172,414 shares to his holdings on June 16, at a price of $0.58 per share. These transactions indicate a pattern of accumulation by the company's top executives.
Other Institutional Activity in OneMedNet Corporation
Institutional investors have also been adjusting their stakes in OneMedNet. Exencial Wealth Advisors increased its holdings by 4,732,698 shares, resulting in a total of 8,377,559 shares valued at approximately $7.12 million, reflecting a 129.8% increase. Vanguard Capital Management opened a new position with 1,115,565 shares worth about $948,230. Geode Capital Management added 41,802 shares, bringing its total to 338,528 shares valued at $287,782, marking a 14.1% increase. Additionally, Vanguard Fiduciary Trust Co and Citigroup Inc both initiated new positions, each acquiring over 135,000 shares.
OneMedNet Corporation Stock Up 3.2%
As of Wednesday, shares of OneMedNet Corporation (NasdaqCM: ONMD) traded at $0.64. The company has a market cap of roughly $30.4 million and a beta of 1.122, indicating moderate volatility. Over the past year, the stock has seen a low of $0.34 and a high of $4.22. The 50-day moving average is $0.85, while the 200-day moving average stands at $1.15. However, with a current ratio of 0.273 and a quick ratio of 0.174, the company's liquidity appears tight.
$ONMD stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
OneMedNet reported revenue of $1.32 million, though it experienced a revenue decline of 29.9%. The company is not yet profitable, with a net margin of -254.325%. As a result, it has no meaningful P/E ratio. The company’s financials highlight ongoing challenges in achieving profitability.
About OneMedNet Corporation
OneMedNet Corporation is a healthcare software company based in Eden Prairie, Minnesota. It specializes in digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. Its products include iRWD, which provides regulatory-grade imaging and clinical data for the pharmaceutical and device manufacturing sectors, and BEAM, a platform for medical imaging exchange among healthcare systems and patients. Led by CEO Aaron Green, the company employs 22 people.
Bottom Line
Insider purchases by Jeffrey Yu and other executives suggest confidence in OneMedNet Corporation's future. The company's stock, while volatile, remains of interest to both insiders and institutional investors. However, the financials indicate challenges, as reflected in recent revenue declines and negative margins. Investors and analysts continue to watch for signs of a turnaround as the company navigates its financial landscape.
Get OneMedNet Corporation alerts
New 13F filings, insider trades, and analyst moves on $ONMD, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.